Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
For bpc-157 tb-500 blend, the first practical step is to separate human evidence from preclinical or anecdotal claims
Feelings of nausea, a disrupted stomach, or diarrhea
Across two phase 1 studies, subjects receiving subcutaneous bremelanotide experienced significantly greater weight loss than placebo over short treatment periods
Shop Now to get started
The peptide has never undergone formal FDA review, and it remains available exclusively through 503A compounding pharmacies under prescriber supervision
SEC filings 2024-2025
US$ 24.82
US$ 29.10
US$ 22.18
US$ 26.37
US$ 20.23
US$ 28.32
US$ 24.72
US$ 26.57
US$ 22.68
US$ 24.87
